South & Central America Lateral Flow Assay Market Forecast to 2030
South & Central America Lateral Flow Assay Market Forecast to 2030 – Regional Analysis – by Product Type (Kits & Reagents and Lateral Flow Readers), Technique (Sandwich Assay, Competitive Assays, and Multiplex Detection Assay), Test Type (Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, and Drug Development & Quality Testing), and End User (Hospitals and Clinics, Diagnostics Laboratories, Homecare, Veterinary Clinics, Pharmaceutical & Biotechnology Companies, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Evolving Applications of Lateral Flow Assays Fuel South & Central America Lateral Flow Assay Market
Lateral flow assays are widely used for infectious disease diagnosis, heart disease diagnosis, and veterinary applications. However, the scope of their applications has expanded in recent years. Behavioral health, saliva-based diagnostics, biological warfare (detection of Bacillus anthracis), environmental testing (detection of contaminating enzymes in production facilities), agriculture (detection of genetically modified organisms and quality control of plants), food microbiology (Detection of E. coli O157, Salmonella, Listeria, and other food spoilage bacteria) have emerged as new application areas for lateral flow assays.
Atlas-Link Biotech (Beijing) provides FASPIT Antigen Saliva Test Kit. NOVA Test SARS-CoV-2 Antigen Saliva Test Kit (Colloidal Gold Immunochromatography) is a lateral flow assay that uses the double-antibody sandwich method to detect the SARS-CoV-2 nucleocapsid protein from saliva specimens from patients who are suspected of SARS-CoV-2 by a healthcare provider. Only certified laboratories that meet the requirements for performing moderate, high, or waived complexity tests can perform such saliva-based tests. The SARS-CoV-2 antigen saliva test kits provide preliminary test results, with negative results that don’t preclude SARS-CoV-2 infection.
South & Central America Lateral Flow Assay Market Overview
The South & Central America lateral flow assay market is segmented into Brazil, Argentina, and the Rest of South & Central America. The increase in the adoption of lateral flow assay-based rapid antigen test kits, a rise in the incidence of infectious diseases, and increasing market developments are among the factors contributing to the market growth in the region.
Brazil has a well-established medical device industry. The country has the region’s most significant medical industry and is the US’s largest importer of medical products.
The International Trade Administration (the US Department of Commerce) reported that in 2020, Brazil increased imports of medical devices by 12.9%, reaching US$ 6.2 billion in imports. The Brazilian National Health Surveillance Agency (ANVISA) regulates the safe usage of medical devices and in vitro diagnostic (IVD) products. In January 2022, ANVISA approved a new regulation allowing pharmacies and healthcare retailers to facilitate the distribution and sale of at-home self-test kits to detect SARS-CoV-2. ANVISA also notified Brazilian Registration Holders (BRH) to register any COVID-19 rapid antigen self-test device before importing, marketing, or distributing across the nation. Thus, the approval of regulation to distribute and sell COVID-19 rapid test kits in Brazil fueled the market growth.
South & Central America Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Lateral Flow Assay Market Segmentation
The South & Central America lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.
Based on product type, the South & Central America lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger South & Central America lateral flow assay market share in 2022.
In terms of technique, the South & Central America lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest South & Central America lateral flow assay market share in 2022.
By test type, the South & Central America lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger South & Central America lateral flow assay market share in 2022.
Based on application, the South & Central America lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest South & Central America lateral flow assay market share in 2022.
By end user, the South & Central America lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest South & Central America lateral flow assay market share in 2022.
By country, the South & Central America lateral flow assay market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lateral flow assay market share in 2022.
F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America lateral flow assay market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the South & Central America lateral flow assay market was valued at US$ 511.69 million in 2022 and is expected to reach US$ 837.33 million by 2030, registering a CAGR of 6.3% from 2022 to 2030. Smartphone usage and AI integration in lateral flow immunoassay and evolving applications of lateral flow assays are among the critical factors attributed to drive the South & Central America lateral flow assay market growth.
Smartphone-based biosensors in optical procedures involving mechanisms such as reflection, absorption, and fluorescence have been instrumental in diagnostics, medical, healthcare, food, and environmental monitoring applications. Artificial intelligence (AI) and machine learning are major technologies that drive this progress, providing real-time and highly accurate reads. With machine learning, reader software can quickly adapt to new tests launched by manufacturers.
Further, cloud-based systems may turn any tablet or smartphone into a universal digital reader, allowing healthcare organizations to perform lateral flow tests for the detection of any infection or marker on a large scale. This system allows any smartphone or tablet to become a universal digital reader, allowing healthcare organizations to roll out lateral flow testing for any disease or marker at scale. Furthermore, AI-driven innovative devices that can read a COVID-19 lateral flow diagnostic test using a user’s smartphone have received special use approval from the Medicines and Healthcare Products Regulatory Agency (MHRA). Thus, AI integration and smartphone usage are likely to trigger the demand for lateral flow assays in the healthcare sector in the coming years.
On the contrary, inconsistent assay results due to procedural limitations hamper the growth of South & Central America lateral flow assay market.
Based on product type, the South & Central America lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held 63.6% market share in 2022, amassing US$ 325.44 million. It is projected to garner US$ 556.01 million by 2030 to register 6.9% CAGR during 2022-2030.
In terms of technique, the South & Central America lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held 45.7% share of South & Central America lateral flow assay market in 2022, amassing US$ 233.66 million. It is anticipated to garner US$ 380.87 million by 2030 to expand at 6.3% CAGR during 2022-2030.
By test type, the South & Central America lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held 60.9% share of South & Central America lateral flow assay market in 2022, amassing US$ 311.75 million. It is projected to garner US$ 534.62 million by 2030 to expand at 7.0% CAGR from 2022 to 2030.
Based on application, the South & Central America lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held 77.1% share of South & Central America lateral flow assay market in 2022, amassing US$ 394.53 million. It is predicted to garner US$ 647.10 million by 2030 to expand at 6.4% CAGR between 2022 and 2030.
By end user, the South & Central America lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held 50.3% share of South & Central America lateral flow assay market in 2022, amassing US$ 257.21 million. It is estimated to garner US$ 430.90 million by 2030 to expand at 6.7% CAGR during 2022-2030.
Based on country, the South & Central America lateral flow assay market is categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 61.6% share of South & Central America lateral flow assay market in 2022. It was assessed at US$ 315.28 million in 2022 and is likely to hit US$ 548.27 million by 2030, registering a CAGR of 7.2% during 2022-2030.
Key players operating in the South & Central America lateral flow assay market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc, among others.
In May 2022, Bio-Rad Laboratories launched the CFX Duet Real-Time PCR system to support researchers in developing singleplex and duplex quantitative PCR assays. The system offers the robust thermal performance and proprietary, accurate optical shuttle system of the company’s CFX Opus system.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America lateral flow assay market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America lateral flow assay market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Lateral Flow Assay Market – Key Industry Dynamics
4.1 South & Central America Lateral Flow Assay Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Use of Home-Based Assay Kits
4.2.2 Rising Popularity of Point-of-Care Testing
4.3 Market Restraints
4.3.1 Inconsistent Assay Results Due to Procedural Limitations
4.4 Market Opportunities
4.4.1 Evolving Applications of Lateral Flow Assays
4.5 Future Trends
4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
4.6 Impact analysis
5. Lateral Flow Assay Market – South & Central America Market Analysis
5.1 South & Central America Lateral Flow Assay Market Revenue (US$ Mn), 2020 – 2030
6. South & Central America Lateral Flow Assay Market Analysis – Product Type
6.1 Kits & Reagents
6.1.1 Overview
6.1.2 Kits & Reagents: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Lateral Flow Readers
6.2.1 Overview
6.2.2 Lateral Flow Readers: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Lateral Flow Assay Market Analysis – Technique
7.1 Sandwich Assay
7.1.1 Overview
7.1.2 Sandwich Assay: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Competitive Assays
7.2.1 Overview
7.2.2 Competitive Assays: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Multiplex Detection Assay
7.3.1 Overview
7.3.2 Multiplex Detection Assay: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Lateral Flow Assay Market Analysis – Test Type
8.1 Lateral Flow Immunoassay
8.1.1 Overview
8.1.2 Lateral Flow Immunoassay: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Nucleic Acid Lateral Flow Assay
8.2.1 Overview
8.2.2 Nucleic Acid Lateral Flow Assay: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Lateral Flow Assay Market Analysis – Application
9.1 Clinical Testing
9.1.1 Overview
9.1.2 Clinical Testing: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Veterinary Diagnostics
9.2.1 Overview
9.2.2 Veterinary Diagnostics: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Food Safety & Environment Testing
9.3.1 Overview
9.3.2 Food Safety & Environment Testing: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Development & Quality Testing
9.4.1 Overview
9.4.2 Drug Development & Quality Testing: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Lateral Flow Assay Market Analysis – End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.2 Diagnostics Laboratories
10.2.1 Overview
10.2.2 Diagnostics Laboratories: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.3 Homecare
10.3.1 Overview
10.3.2 Homecare: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.4 Veterinary Clinics
10.4.1 Overview
10.4.2 Veterinary Clinics: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.5 Pharmaceutical & Biotechnology Companies
10.5.1 Overview
10.5.2 Pharmaceutical & Biotechnology Companies: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Lateral Flow Assay Market – Country Analysis
11.1 South & Central America Lateral Flow Assay Market, Revenue and Forecast to 2030
11.1.1 South & Central America Lateral Flow Assay Market Revenue and Forecasts and Analysis – By Country
11.1.1.1 Brazil: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.1.1 Overview
11.1.1.1.2 Brazil Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.1.3 Brazil Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
11.1.1.1.4 Brazil Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
11.1.1.1.5 Brazil Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
11.1.1.1.6 Brazil Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
11.1.1.1.7 Brazil Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Argentina: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.2.1 Overview
11.1.1.2.2 Argentina Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.2.3 Argentina Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
11.1.1.2.4 Argentina Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
11.1.1.2.5 Argentina Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
11.1.1.2.6 Argentina Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.7 Argentina Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Rest of South & Central America: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.3.1 Overview
11.1.1.3.2 Rest of South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.3.3 Rest of South & Central America Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
11.1.1.3.4 Rest of South & Central America Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
11.1.1.3.5 Rest of South & Central America Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
11.1.1.3.6 Rest of South & Central America Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.7 Rest of South & Central America Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Lateral Flow Assay Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Becton Dickinson and Co
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hologic Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 QIAGEN NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 bioMerieux SA
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QuidelOrtho Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Abbott Laboratories
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Merck KGaA
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Thermo Fisher Scientific Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 Glossary of Terms
LIST OF TABLES
Table 2. Brazil Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 12. Rest of South & Central America Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Organic Growth Strategies in the Lateral Flow Assay Market
Table 18. Recent Inorganic Growth Strategies in the Lateral Flow Assay Market
Table 19. Glossary of Terms, Lateral Flow Assay Market
Â
LIST OF FIGURES
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Lateral Flow Assay Market Revenue (US$ Mn), 2020 – 2030
Figure 4. South & Central America Lateral Flow Assay Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 5. Kits & Reagents: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Lateral Flow Readers: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. South & Central America Lateral Flow Assay Market Revenue Share, by Technique, 2022 & 2030 (%)
Figure 8. Process of Sandwich Lateral Flow Assay
Figure 9. Sandwich Assay: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Process of Competitive Lateral Flow Assay
Figure 11. Competitive Assays: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Multiplex Detection Assay: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. South & Central America Lateral Flow Assay Market Revenue Share, by Test Type, 2022 & 2030 (%)
Figure 14. Lateral Flow Immunoassay: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Nucleic Acid Lateral Flow Assay: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. South & Central America Lateral Flow Assay Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 17. Clinical Testing: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Veterinary Diagnostics: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Food Safety & Environment Testing: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Drug Development & Quality Testing: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. South & Central America Lateral Flow Assay Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Hospitals and Clinics: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Diagnostics Laboratories: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Homecare: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. Veterinary Clinics: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 26. Pharmaceutical & Biotechnology Companies: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Others: South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Lateral Flow Assay Market, by Key Country – Revenue (2022) (US$ Million)
Figure 29. South & Central America Lateral Flow Assay Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 30. Brazil Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 31. Argentina Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 32. Rest of South & Central America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 33. Growth Strategies in the Lateral Flow Assay Market
1. F. Hoffmann-La Roche Ltd
2. Siemens Healthineers AG
3. Becton Dickinson and Co
4. PerkinElmer Inc
5. Hologic Inc
6. QIAGEN NV
7. bioMerieux SA
8. QuidelOrtho Corp
9. Abbott Laboratories
10. Merck KGaA
11. Bio-Rad Laboratories Inc
12. Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.